Uncategorized

Drug Therapies Showing Greater Promise for Pre-Kidney Transplant Patients

Early findings by researchers at the University of Cincinnati (UC) College of Medicine suggest that the use of a second generation cancer drug, carfilzomib, may provide an improved approach for the reduction of antibodies in potential kidney transplant candidates. The research team includes members from UC Transplant Clinical Research, UC’s Division of Hematology Oncology and […]